Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
Ann Palliat Med ; 11(1): 378-383, 2022 01.
Article in English | MEDLINE | ID: covidwho-1687682

ABSTRACT

In this paper, we report a case of coronavirus disease 2019 (COVID-19) complicated with human immunodeficiency virus (HIV) infection. The 50-year-old male patient had unexplained "intermittent fever with sore throat" on February 9th, 2020. Chest computed tomography (CT) showed bilateral multiple patchy opacities and ground-glass opacities. A COVID-19 RNA test was positive. After admission, additional laboratory tests revealed the following: white blood cell (WBC) count, 4.7×109/L; neutrophil percentage, 85.1%; lymphocyte percentage, 12.3%; lymphocyte count, 0.59×109/L; hypersensitivity C-reactive protein, 5.52 mg/L; four coagulation factors, +; D-dimer, 1.32 mg/L; and procalcitonin, normal. He was HIV (+). The patient was diagnosed with COVID-19 complicated with HIV infection. The healthcare team administered symptomatic care, including nasal oxygen, oseltamivir, Lianhua Qingwen capsule, moxifloxacin, ribavirin, and thymus faxin, as well as nutritional support, mental care, diet and life management, and close monitoring. Moreover, the team implemented strict disinfection and quarantine and occupational protection. The patient's temperature returned to normal and sore throat significantly improved by day 10, and COVID-19 RNA tests were negative on February 19th, February 21st, and February 22nd. Reexamination by chest CT on February 22nd showed significant absorption of inflammation. After rounds by the chief physician and consultation with specialists, the patient was released from quarantine and discharged on February 23rd per the Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 6). Patients with COVID-19 and HIV infection face both physical and mental challenges. More attention should be paid to nursing as we understand more about COVID-19. We hope to share our nursing experience through this case.


Subject(s)
COVID-19 , HIV Infections , HIV , Humans , Male , Middle Aged , Quarantine , SARS-CoV-2
2.
Ann Palliat Med ; 10(6): 7107-7113, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1296309

ABSTRACT

Coronavirus disease 2019 (COVID-19), an acute infectious disease, which is characterized by influenza, fever, cough and dyspnea. Up to now, the pathogenic mechanism and radical cure treatment for COVID-19 are still unknown. However, COVID-19 could lead to pneumonia, multiple organ failure and even death with disease development. During the period of February 10 and March 26, 2020, we admitted and treated three COVID-19 patients complicated with acute myocardial infarction. As we all know, acute myocardial infarction is a kind of disease that induces myocardial ischemia necrosis and leads to high mortality. Through the three COVID-19 patients complicated with acute myocardial infarction, we have strengthened our nursing experience. Thus, we wish to share our nursing experience with these cases by analyzing the etiology of three patients with coronavirus disease 2019 (COVID-19) complicated with acute myocardial infarction in this paper. First, we retrospectively analyzed the clinical data, including patient complaints, diagnosis, treatment, and prognosis, of three patients with COVID-19 complicated with acute myocardial infarction admitted to Ward II, Department of Infectious Diseases III, Huoshenshan Hospital, Wuhan, Hubei Province, China, between February 10 and March 26, 2020. Then, we searched for relevant literature, analyzed etiology, and summarized the nursing measures taken. For COVID-19 patients with a high risk of acute myocardial infarction, nurses should stay vigilant, closely monitor any change in condition, and implement early measures to maintain vital signs and enable timely visits with specialists. Finally, we importantly found that these nursing measures are keys to managing the patient's condition, improving patient outcomes, and increasing the chance of treatment success.


Subject(s)
COVID-19 , Myocardial Infarction , China , Humans , Retrospective Studies , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL